GWH - ARWR CRDF and ORTX among pre market gainers
Dicerna Pharmaceuticals DRNA +78% Novo Nordisk agrees to acquire Dicerna for more than $3 billion Cardiff Oncology (NASDAQ:CRDF) +23% announces $15M equity investment from Pfizer through its Pfizer breakthrough growth initiative Cloopen Group Holding RAAS +19% on Q3 results Sono Group SEV +11% Hot Stocks: SEV IPO; RACE rallies; ATVI scandal continues; SAVA probe; oil and gas stocks fall Arcus Biosciences RCUS +11% after Gilead exercises options to three clinical-stage programs Lion Group Holding (NASDAQ:LGHL) +11% signs letter of intent with New Full Rich to invest in Tajikistan's digital mining project Victoria's Secret VSCO +11% on Q3 results AiHuiShou International RERE +11% on Q3 results ZTO Express ZTO +11% on Q3 results BM Technologies (NYSE:BMTX) +11%. Pasithea Therapeutics (NASDAQ:KTTA) +11%. Macy's M +10% on Q3 results Unity Biotechnology (NASDAQ:UBX) +10%. ESS Tech (NYSE:GWH) +10%. Kohl's KSS +9% on Q3 results Arrowhead Pharmaceuticals (NASDAQ:ARWR) +8%. NVIDIA NVDA +8% on Q3 results Longeveron (NASDAQ:LGVN) +7%. U.S. food and drug administration approves Longeveron’s Lomecel-B for rare pediatric disease designation to
For further details see:
ARWR, CRDF and ORTX among pre market gainers